Hosted on MSN
Boston Scientific raises 2025 organic growth guidance to 15.5% amid WATCHMAN and EP momentum
CEO Michael Mahoney reported, “In third quarter '25, total company operational sales grew 19% and organic sales grew 15%, exceeding the high end of our guidance range of 12% to 14%, with sustained ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results